======= PHF19 ======= == Gene Information == * **Official Symbol**: PHF19 * **Official Name**: PHD finger protein 19 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=26147|26147]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5T6S3|Q5T6S3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PHF19&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PHF19|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609740|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Polycomb group (PcG) that specifically binds histone H3 trimethylated at 'Lys-36' (H3K36me3) and recruits the PRC2 complex. Probably involved in the transition from an active state to a repressed state in embryonic stem cells: acts by binding to H3K36me3, a mark for transcriptional activation, and recruiting H3K36me3 histone demethylases RIOX1 or KDM2B, leading to demethylation of H3K36 and recruitment of the PRC2 complex that mediates H3K27me3 methylation, followed by de novo silencing. Recruits the PRC2 complex to CpG islands and contributes to embryonic stem cell self-renewal. Also binds dimethylated at 'Lys- 36' (H3K36me2). Isoform 1 and isoform 2 inhibit transcription from an HSV-tk promoter. {ECO:0000269|PubMed:15563832, ECO:0000269|PubMed:21143197, ECO:0000269|PubMed:23104054, ECO:0000269|PubMed:23160351}. |PHD| |positive regulation of histone H3-K27 methylation| |regulation of histone H3-K27 methylation| |ESC/E(Z) complex| |nucleosome binding| |positive regulation of histone methylation| |methylated histone binding| |regulation of histone methylation| |negative regulation of gene expression, epigenetic| |positive regulation of histone modification| |positive regulation of chromatin organization| |regulation of histone modification| |positive regulation of chromosome organization| |regulation of chromatin organization| |regulation of gene expression, epigenetic| |regulation of chromosome organization| |sequence-specific DNA binding| |positive regulation of organelle organization| |DNA-binding transcription factor activity| |chromatin organization| |chromosome organization| |positive regulation of cellular component organization| |positive regulation of protein modification process| |regulation of organelle organization| |positive regulation of transcription, DNA-templated| |positive regulation of cellular protein metabolic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp93|DABN racemic mixture R03 exp93]]|-1.99| |[[:results:exp346|CoCl2 18μM R07 exp346]]|-1.75| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-1.7| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12370 * **Expression level (log2 read counts)**: 6.3 {{:chemogenomics:nalm6 dist.png?nolink |}}